Fred Alger Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374K | Buy |
+9,464
| New | +$374K | ﹤0.01% | 394 |
|
|
2024
Q1 | – | Sell |
-24,054
| Closed | -$1.22M | – | 469 |
|
|
2023
Q4 | $1.22M | Buy |
24,054
+10,488
| +77% | +$531K | 0.01% | 362 |
|
|
2023
Q3 | $615K | Buy |
+13,566
| New | +$615K | ﹤0.01% | 370 |
|
|
2023
Q2 | – | Sell |
-499
| Closed | -$17.8K | – | 546 |
|
|
2023
Q1 | $17.8K | Sell |
499
-189,854
| -100% | -$6.79M | ﹤0.01% | 500 |
|
|
2022
Q4 | $7.19M | Buy |
190,353
+47,831
| +34% | +$1.81M | 0.04% | 232 |
|
|
2022
Q3 | $6.3M | Sell |
142,522
-4,134
| -3% | -$183K | 0.03% | 239 |
|
|
2022
Q2 | $5.43M | Buy |
+146,656
| New | +$5.43M | 0.03% | 258 |
|
|
2019
Q4 | – | Sell |
-190
| Closed | -$11K | – | 501 |
|
|
2019
Q3 | $11K | Sell |
190
-240
| -56% | -$13.9K | ﹤0.01% | 472 |
|
|
2019
Q2 | $28K | Buy |
430
+189
| +78% | +$12.3K | ﹤0.01% | 437 |
|
|
2019
Q1 | $20K | Buy |
+241
| New | +$20K | ﹤0.01% | 439 |
|
|
2018
Q2 | – | Sell |
-4,000
| Closed | -$176K | – | 562 |
|
|
2018
Q1 | $176K | Buy |
+4,000
| New | +$176K | ﹤0.01% | 398 |
|
|
2017
Q1 | – | Sell |
-6,000
| Closed | -$287K | – | 538 |
|
|
2016
Q4 | $287K | Buy |
+6,000
| New | +$287K | ﹤0.01% | 344 |
|
|
2015
Q2 | – | Sell |
-161,972
| Closed | -$10.3M | – | 517 |
|
|
2015
Q1 | $10.3M | Sell |
161,972
-125,107
| -44% | -$7.97M | 0.05% | 260 |
|
|
2014
Q4 | $17.7M | Buy |
287,079
+143,042
| +99% | +$8.83M | 0.09% | 195 |
|
|
2014
Q3 | $5.59M | Sell |
144,037
-30,413
| -17% | -$1.18M | 0.03% | 328 |
|
|
2014
Q2 | $6.01M | Sell |
174,450
-156,405
| -47% | -$5.39M | 0.03% | 344 |
|
|
2014
Q1 | $14.3M | Buy |
330,855
+48,395
| +17% | +$2.09M | 0.07% | 263 |
|
|
2013
Q4 | $11.3M | Buy |
+282,460
| New | +$11.3M | 0.06% | 289 |
|